180 related articles for article (PubMed ID: 20943276)
1. The immunological basis for treatment of stiff person syndrome.
Holmøy T; Geis C
J Neuroimmunol; 2011 Feb; 231(1-2):55-60. PubMed ID: 20943276
[TBL] [Abstract][Full Text] [Related]
2. Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition.
Geis C; Weishaupt A; Hallermann S; Grünewald B; Wessig C; Wultsch T; Reif A; Byts N; Beck M; Jablonka S; Boettger MK; Üçeyler N; Fouquet W; Gerlach M; Meinck HM; Sirén AL; Sigrist SJ; Toyka KV; Heckmann M; Sommer C
Brain; 2010 Nov; 133(11):3166-80. PubMed ID: 20884644
[TBL] [Abstract][Full Text] [Related]
3. [Stiff-person syndrome and related autoantibodies].
Tomioka R; Tanaka K
Brain Nerve; 2013 Apr; 65(4):395-400. PubMed ID: 23568987
[TBL] [Abstract][Full Text] [Related]
4. [Stiff-person syndrome and other myelopathies constitute paraneoplastic neurological syndromes].
Ishii A
Brain Nerve; 2010 Apr; 62(4):377-85. PubMed ID: 20420178
[TBL] [Abstract][Full Text] [Related]
5. Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies.
Ali F; Rowley M; Jayakrishnan B; Teuber S; Gershwin ME; Mackay IR
J Autoimmun; 2011 Sep; 37(2):79-87. PubMed ID: 21680149
[TBL] [Abstract][Full Text] [Related]
6. Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats.
Hansen N; Grünewald B; Weishaupt A; Colaço MN; Toyka KV; Sommer C; Geis C
Exp Neurol; 2013 Jan; 239():202-9. PubMed ID: 23099416
[TBL] [Abstract][Full Text] [Related]
7. GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient.
Schloot NC; Batstra MC; Duinkerken G; De Vries RR; Dyrberg T; Chaudhuri A; Behan PO; Roep BO
J Autoimmun; 1999 Jun; 12(4):289-96. PubMed ID: 10330300
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome.
Skorstad G; Hestvik AL; Vartdal F; Holmøy T
J Autoimmun; 2009 Feb; 32(1):24-32. PubMed ID: 19027267
[TBL] [Abstract][Full Text] [Related]
9. Evidence of T-cell mediated neuronal injury in stiff-person syndrome with anti-amphiphysin antibodies.
Poh MQ; Simon NG; Buckland ME; Salisbury E; Watson S
J Neurol Sci; 2014 Feb; 337(1-2):235-7. PubMed ID: 24405658
[TBL] [Abstract][Full Text] [Related]
10. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
[TBL] [Abstract][Full Text] [Related]
11. Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome.
Rizzi M; Knoth R; Hampe CS; Lorenz P; Gougeon ML; Lemercier B; Venhoff N; Ferrera F; Salzer U; Thiesen HJ; Peter HH; Walker UA; Eibel H
PLoS One; 2010 May; 5(5):e10838. PubMed ID: 20520773
[TBL] [Abstract][Full Text] [Related]
12. [Stiff person syndrome (Moersch-Woltman)].
Cerimagić D; Bilić E
Lijec Vjesn; 2010; 132(3-4):110-4. PubMed ID: 20540439
[TBL] [Abstract][Full Text] [Related]
13. Protective and detrimental immunity: lessons from stiff person syndrome and multiple sclerosis.
Holmøy T; Skorstad G; Hestvik AL; Alvik KM; Vartdal F
Acta Neurol Scand Suppl; 2009; (189):22-6. PubMed ID: 19566493
[TBL] [Abstract][Full Text] [Related]
14. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition.
Daw K; Ujihara N; Atkinson M; Powers AC
J Immunol; 1996 Jan; 156(2):818-25. PubMed ID: 8543838
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
16. [Stiff-Person Syndrome and Related Autoantibodies].
Matsui N; Tanaka K; Kaji R
Brain Nerve; 2018 Apr; 70(4):357-362. PubMed ID: 29632283
[TBL] [Abstract][Full Text] [Related]
17. Characterization of CD4+ T cells specific for glutamic acid decarboxylase (GAD65) and proinsulin in a patient with stiff-person syndrome but without type 1 diabetes.
Hänninen A; Soilu-Hänninen M; Hampe CS; Deptula A; Geubtner K; Ilonen J; Knip M; Reijonen H
Diabetes Metab Res Rev; 2010 May; 26(4):271-9. PubMed ID: 20503259
[TBL] [Abstract][Full Text] [Related]
18. GAD65 IgG autoantibodies in stiff person syndrome: clonality, avidity and persistence.
Skorstad G; Hestvik AL; Torjesen P; Alvik K; Vartdal F; Vandvik B; Holmøy T
Eur J Neurol; 2008 Sep; 15(9):973-80. PubMed ID: 18637036
[TBL] [Abstract][Full Text] [Related]
19. Rituximab treatment of stiff-person syndrome in a patient with thymoma, diabetes mellitus and autoimmune thyroiditis.
Dupond JL; Essalmi L; Gil H; Meaux-Ruault N; Hafsaoui C
J Clin Neurosci; 2010 Mar; 17(3):389-91. PubMed ID: 20071184
[TBL] [Abstract][Full Text] [Related]
20. Stiff-three limbs syndrome.
Teive HA; Munhoz RP; Cardoso J; Amaral VC; Werneck LC
Mov Disord; 2009 Jan; 24(2):311-2. PubMed ID: 18951538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
